Cognoa

Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. Its ai technology platform will enable the product pipeline to address additional unmet needs including adhd and anxiety. It is focused on improving the lives and outcomes of children and families living with behavioral conditions.

Cognoa headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $10.2B in funding across 80 round(s). With a team of 51-100 employees, Cognoa is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Cognoa, raised $45.1M. Discover more about their projects, partnerships, and impact on our platform.